Par Drugs and Chemicals Limited reports a change in its board or management
In short
Par Drugs and Chemicals Limited informed the NSE on August 22, 2026, about a change in its directors/KMP/SMP/auditor/RTA. No figures, breakdowns, deadlines, or validity periods are stated in the text. In simple terms, the company is notifying the exchange that there has been a change in its leadership or related service providers. No closing date or scheme validity period is given.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.